<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>震惊！基因泰克将关闭癌症免疫学研究部门，明星科学家将离职 - 文字轨迹</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/2024-09/%E9%9C%87%E6%83%8A_%E5%9F%BA%E5%9B%A0%E6%B3%B0%E5%85%8B%E5%B0%86%E5%85%B3%E9%97%AD%E7%99%8C%E7%97%87%E5%85%8D%E7%96%AB%E5%AD%A6%E7%A0%94%E7%A9%B6%E9%83%A8%E9%97%A8_%E6%98%8E%E6%98%9F%E7%A7%91%E5%AD%A6%E5%AE%B6%E5%B0%86%E7%A6%BB%E8%81%8C/"><meta property="og:site_name" content="文字轨迹"><meta property="og:title" content="震惊！基因泰克将关闭癌症免疫学研究部门，明星科学家将离职"><meta property="og:description" content="震惊！基因泰克将关闭癌症免疫学研究部门，明星科学家将离职 by 药时代 【药时代编者按】我们不愿意做标题党，本文标题使用“震惊”一词是基于我们看到外媒报道文章时的第一反应。2024年8月17日，星期六，上海阳光明媚，晴空万里。但药时代团队的心头却布满了乌云，为什么呢？因为Endpoints News、Fierce Biotech等多家知名外媒先后报道了一条关于基因泰克的爆炸性新闻，“基因泰克将关闭癌症免疫学研究部门，明星科学家将离职”。（图片来源：Endpoints News截屏）"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2024-09-10T07:24:20+00:00"><meta property="article:modified_time" content="2024-09-10T07:24:20+00:00"><meta property="article:tag" content="Fetched"><meta property="article:tag" content="药时代"><meta itemprop=name content="震惊！基因泰克将关闭癌症免疫学研究部门，明星科学家将离职"><meta itemprop=description content="震惊！基因泰克将关闭癌症免疫学研究部门，明星科学家将离职 by 药时代 【药时代编者按】我们不愿意做标题党，本文标题使用“震惊”一词是基于我们看到外媒报道文章时的第一反应。2024年8月17日，星期六，上海阳光明媚，晴空万里。但药时代团队的心头却布满了乌云，为什么呢？因为Endpoints News、Fierce Biotech等多家知名外媒先后报道了一条关于基因泰克的爆炸性新闻，“基因泰克将关闭癌症免疫学研究部门，明星科学家将离职”。（图片来源：Endpoints News截屏）"><meta itemprop=datePublished content="2024-09-10T07:24:20+00:00"><meta itemprop=dateModified content="2024-09-10T07:24:20+00:00"><meta itemprop=wordCount content="79"><meta itemprop=keywords content="Fetched,药时代"><meta name=twitter:card content="summary"><meta name=twitter:title content="震惊！基因泰克将关闭癌症免疫学研究部门，明星科学家将离职"><meta name=twitter:description content="震惊！基因泰克将关闭癌症免疫学研究部门，明星科学家将离职 by 药时代 【药时代编者按】我们不愿意做标题党，本文标题使用“震惊”一词是基于我们看到外媒报道文章时的第一反应。2024年8月17日，星期六，上海阳光明媚，晴空万里。但药时代团队的心头却布满了乌云，为什么呢？因为Endpoints News、Fierce Biotech等多家知名外媒先后报道了一条关于基因泰克的爆炸性新闻，“基因泰克将关闭癌症免疫学研究部门，明星科学家将离职”。（图片来源：Endpoints News截屏）"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=文字轨迹 rel=home><div class="logo__item logo__text"><div class=logo__title>文字轨迹</div><div class=logo__tagline>故事流淌过的地方</div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>文章</span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>标签</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>关于</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>震惊！基因泰克将关闭癌症免疫学研究部门，明星科学家将离职</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2024-09-10T07:24:20Z>2024-09-10</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/duty/ rel=category>Duty</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#震惊基因泰克将关闭癌症免疫学研究部门明星科学家将离职-by-药时代>震惊！基因泰克将关闭癌症免疫学研究部门，明星科学家将离职 by 药时代</a></li></ul></nav></div></div><div class="content post__content clearfix"><h2 id=震惊基因泰克将关闭癌症免疫学研究部门明星科学家将离职-by-药时代>震惊！基因泰克将关闭癌症免疫学研究部门，明星科学家将离职 by 药时代</h2><div><p data-mpa-powered-by=yiban.io><img data-backh=193 data-backw=578 data-imgfileid=100850993 data-ratio=0.3333333333333333 data-s=300,640 data-src="https://mmbiz.qpic.cn/sz_mmbiz_gif/Lkw2iaE07M9VGl240HN1UR5tUO8qrzkA44F2wy21t8QRY7ialNrScBGQDTXsIaqkX07DJ7notXWWZictyU6ku2aIQ/640?wx_fmt=gif" data-type=gif data-w=900 src="https://mmbiz.qpic.cn/sz_mmbiz_gif/Lkw2iaE07M9VGl240HN1UR5tUO8qrzkA44F2wy21t8QRY7ialNrScBGQDTXsIaqkX07DJ7notXWWZictyU6ku2aIQ/640?wx_fmt=gif"></p><section><mp-common-videosnap data-pluginname=mpvideosnap data-headimgurl=https://wx.qlogo.cn/finderhead/Q3auHgzwzM4njP4xWmU6ia9smibzXzLWAg6rrbEuZuiaQlgrM8dYRicffA/0 data-username=v2_060000231003b20faec8c7e38d1ac2d6c903ed35b0779629073dbff92eb25305ea1c0e2b627a@finder data-nickname=药时代 data-desc="将在08月22日 19:00 直播" data-livewording=预约 data-intro=攻克实体瘤，细胞疗法准备好了吗？——大话CGT系列第3场 data-type=live data-status=0 data-noticeid=finderlivenotice-v2_060000231003b20faec8c7e38d1ac2d6c903ed35b0779629073dbff92eb25305ea1c0e2b627a@finder-1723770811457150-659869594 data-isdisabled=0 data-errortips></mp-common-videosnap></section><section><span>【药时代编者按】我们不愿意做标题党，本文标题使用“震惊”一词是基于我们看到外媒报道文章时的第一反应。</span><span></span></section><section><span>2024年8月17日，星期六，上海阳光明媚，晴空万里。但药时代团队的心头却布满了乌云，为什么呢？因为<span>Endpoints News、</span>Fierce Biotech等多家知名外媒先后报道了一条关于基因泰克的爆炸性新闻，“<strong>基因泰克将关闭癌症免疫学研究部门，明星科学家将离职</strong>”。</span></section><section><img data-backh=476 data-backw=578 data-galleryid data-imgfileid=100850992 data-ratio=0.8240740740740741 data-s=300,640 data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/Lkw2iaE07M9We2mn423tWOicNIXmvrSA0FjnXicjiaI6OSxmCHHo6E7x40MysViarMgz8iaTd39lmW6NI022gQqpVUEQ/640?wx_fmt=png&amp;from=appmsg" data-type=png data-w=1080 src="https://mmbiz.qpic.cn/sz_mmbiz_png/Lkw2iaE07M9We2mn423tWOicNIXmvrSA0FjnXicjiaI6OSxmCHHo6E7x40MysViarMgz8iaTd39lmW6NI022gQqpVUEQ/640?wx_fmt=png&amp;from=appmsg"></section><p><span>（图片来源：Endpoints News截屏</span><span>）</span></p><section><span></span></section><section><img data-backh=218 data-backw=578 data-galleryid data-imgfileid=100850991 data-ratio=0.37777777777777777 data-s=300,640 data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/Lkw2iaE07M9We2mn423tWOicNIXmvrSA0FkRSyDZJePpNpIHt3cKwtpZZAZoO2Qj1WjCl8xEI2q0BmwlQDozUNiag/640?wx_fmt=png&amp;from=appmsg" data-type=png data-w=1080 src="https://mmbiz.qpic.cn/sz_mmbiz_png/Lkw2iaE07M9We2mn423tWOicNIXmvrSA0FkRSyDZJePpNpIHt3cKwtpZZAZoO2Qj1WjCl8xEI2q0BmwlQDozUNiag/640?wx_fmt=png&amp;from=appmsg"></section><p><span>（图片来源：FierceBiotech截屏</span><span>）</span><span></span></p><section><span></span></section><section><span><strong>这令我们倍感震惊，不禁要问：</strong></span></section><section data-mpa-template=t mpa-from-tpl=t><section data-mpa-template=t mpa-from-tpl=t><section mpa-from-tpl=t><section mpa-from-tpl=t><section mpa-from-tpl=t><span mpa-none-content=t>“</span><section mpa-from-tpl=t><br mpa-from-tpl=t></section></section><section mpa-from-tpl=t><section mpa-from-tpl=t><section mpa-from-tpl=t><section mpa-from-tpl=t><span><strong><span mpa-is-content=t>到底发生了什么呢？这对全球癌症免疫学赛道会有怎样的影响呢？</span></strong></span></section></section></section></section><section><section mpa-from-tpl=t><section mpa-from-tpl=t><br mpa-from-tpl=t></section><span mpa-none-content=t>”</span></section></section></section></section></section></section><section><span></span></section><section><p><img data-backh=272 data-backw=578 data-imgfileid=100850995 data-ratio=0.49284928492849284 data-s=300,640 data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/Lkw2iaE07M9We2mn423tWOicNIXmvrSA0FLwPQicgHEc4eNDVCtkZK6UvB49YXDicxYPWfOO7cmzGSQic828lyUSR8Q/640?&amp;wx_fmt=png" data-type=jpeg data-w=909 height=448 width=909 src="https://mmbiz.qpic.cn/sz_mmbiz_png/Lkw2iaE07M9We2mn423tWOicNIXmvrSA0FLwPQicgHEc4eNDVCtkZK6UvB49YXDicxYPWfOO7cmzGSQic828lyUSR8Q/640?&amp;wx_fmt=png"></p><p><span>（图片来源：Genentech</span><span>）</span></p><section><span>基因泰克，作为全</span><span>球领先的生物技术公司之一，披露了一项震惊业界的重大决定：</span><strong><span>基因泰克</span><span>将关闭其癌症免疫学研究部门</span></strong><span>。</span><span>这一决策标志着公司在肿瘤学研究领域的战略重组，同时，该部门负责人、著名细胞生物学家艾拉·梅尔曼（Ira Mellman）博士在公司服务17年后，将于未来几个月离职。</span></section></section><section><span>基因泰克的发言人通过电子邮件向Endpoints News、<span>Fierce Biotech</span>确认了这一消息，并表示：“这一决定是基于我们对如何最好地抓住该领域当前科学机遇的实地评估，而不是基于罗氏关于癌症免疫学的任何整体决策。” 该发言人进一步强调，公司继续相信癌症免疫学是其肿瘤学项目的重要组成部分。</span></section><section><span>此次重组将癌症免疫学研究功能与分子肿瘤学研究合并，形成单一的癌症研究组织，由弗雷德里克·德索维（Frederic de Sauvage）领导。</span></section><section><span>这一变化将影响“有限数量”的员工，但公司未具体透露受影响员工的人数。</span></section><p><img data-imgfileid=100850996 data-ratio=0.6666666666666666 data-s=300,640 data-src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/Lkw2iaE07M9We2mn423tWOicNIXmvrSA0FOGp25ibJ8hTJvl14nh4tE8RLTticqk0icv7I40tQVeH6ZPmmevVJbRkkw/640?wx_fmt=jpeg&amp;from=appmsg" data-type=jpeg data-w=1080 src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/Lkw2iaE07M9We2mn423tWOicNIXmvrSA0FOGp25ibJ8hTJvl14nh4tE8RLTticqk0icv7I40tQVeH6ZPmmevVJbRkkw/640?wx_fmt=jpeg&amp;from=appmsg"></p><p><span>（图片来源：Genentech</span><span>）</span></p><section><span></span></section><section><span>梅尔曼博士在癌症免疫学领域的贡献被广泛认可，包括对内体（endosome）的发现。在基因泰克，监督了包括Tecentriq在内的多个重要药物的发现和发展，Tecentriq作为检查点抑制剂，一直是罗氏肿瘤学产品组合的核心。</span></section><section><span>2013年<span>梅尔曼</span><span>博士与Daniel S. Chen博士联合发表的综述文章《Oncology Meets Immunology: The Cancer-Immunity Cycle》在业界产生了很深的影响。</span><br></span></section><p><img data-croporisrc="https://mmbiz.qpic.cn/sz_mmbiz_png/Lkw2iaE07M9We2mn423tWOicNIXmvrSA0FS5ibyTiaYicP7Q4lwMluSy0iaYdFmITs4gorrkXX6RHib0dZJsiaR7DqT0Eg/0?wx_fmt=png&amp;from=appmsg" data-cropx1=11.100346020761245 data-cropx2=1604 data-cropy1=0 data-cropy2=879.7024221453287 data-galleryid data-imgfileid=100850990 data-ratio=0.5527777777777778 data-s=300,640 data-src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/Lkw2iaE07M9We2mn423tWOicNIXmvrSA0F5DAhman83ic7En0ktzyNbVX1jbicJ3ymficvpgJ0K4sfxibFON1ZwpE4Fw/640?wx_fmt=jpeg" data-type=jpeg data-w=1080 src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/Lkw2iaE07M9We2mn423tWOicNIXmvrSA0F5DAhman83ic7En0ktzyNbVX1jbicJ3ymficvpgJ0K4sfxibFON1ZwpE4Fw/640?wx_fmt=jpeg"></p><p><span>（图片来源：Cell）</span></p><p><span></span></p><section><span>基因泰克的这一决策是在公司面临癌症免疫疗法临床工作挑战后作出的，包括备受关注的抗TIGIT项目tiragolumab的失败，以及与Adaptimmune的同种异体细胞疗法合作的终止。</span></section><section><span><span>Adaptimmune正是全球首款获批的TCR-T疗法的开发者。</span>当地时间2024年8月1日，Adaptimmune宣布旗下TCR-T疗法Afami-cel（商品名：Tecelra）获FDA批准上市，用于晚期滑膜肉瘤的治疗。</span></section><section><span></span></section><p><span>【推荐阅读】</span><span></span></p><ul><li><p><span><a target=_blank href="http://mp.weixin.qq.com/s?__biz=MzI5NzY0NDQyNQ==&amp;mid=2248330577&amp;idx=1&amp;sn=f96a42d71dbc9aa4744737023e7a0366&amp;chksm=ef4795b7d8301ca154362f596ff5847f57b9390cd582879f845a33773511dd84cb2c8e74d526&amp;scene=21#wechat_redirect" textvalue=里程碑！全球首款TCR-T细胞疗法获批上市 linktype=text imgurl imgdata=null data-itemshowtype=0 tab=innerlink data-linktype=2><strong>里程碑！全球首款TCR-T细胞疗法获批上市</strong></a><br></span></p></li><li><h1><a target=_blank href="http://mp.weixin.qq.com/s?__biz=MzI5NzY0NDQyNQ==&amp;mid=2248284451&amp;idx=2&amp;sn=23ffd3a5bbdabadc37aa334819ec63d1&amp;chksm=ef4741c5d830c8d3bd19964d4591f35c509f5a0d258ac6e8e7bbca377eef23f4a68ddde98410&amp;scene=21#wechat_redirect" textvalue=30亿美元合作终止，基因泰克放弃现货型TCR-T细胞疗法开发 linktype=text imgurl imgdata=null data-itemshowtype=11 tab=innerlink data-linktype=2><span><strong>30亿美元合作终止，基因泰克放弃现货型TCR-T细胞疗法开发</strong></span></a></h1></li></ul><section><span></span></section><section><span>作为瑞士制药巨头罗氏的子公司，基因泰克的这一变动也引发了对大型制药公司研发策略的广泛讨论。在成本效益和研发效率的考量下，这一决策可能预示着制药行业在研发模式上的新的转变的开始。</span></section><section><span>基因泰克表示，尽管面临挑战，公司仍将致力于推动癌症治疗的创新和进步。业界普遍关注这一决策将如何影响基因泰克乃至整个制药行业的发展。</span></section><section><span>回到本文开头的问题，</span><span><strong><span mpa-is-content=t>这对全球癌症免疫学赛道会有怎样的影响呢？</span></strong></span></section><section><span><strong><span>欢迎朋友们在评论区留言！</span></strong></span><span></span></section><p><span>参考资料：</span></p><ul><li><p><span>Genentech dissolves cancer immunology group, and research executive Ira Mellman will leave company</span></p></li><li><h1><span>Genentech to shut down cancer immunology research department amid broader R&amp;D rethink</span></h1></li><li><h1><a target=_blank href="http://mp.weixin.qq.com/s?__biz=MzI5NzY0NDQyNQ==&amp;mid=2247518730&amp;idx=1&amp;sn=f4f46377f1182e8b27c84f7acf0128db&amp;chksm=ecb332ecdbc4bbfae9970816cecf7c648551114719fe721bca6801bd41df86a54040ccb1cb58&amp;scene=21#wechat_redirect" textvalue="Fiona Yu专栏 | 倚天屠龙！兼并了基因泰克(Genentech)，罗氏(Roche)能否就此号令群雄？" linktype=text imgurl imgdata=null data-itemshowtype=11 tab=innerlink data-linktype=2><span>Fiona Yu专栏 | 倚天屠龙！兼并了基因泰克(Genentech)，罗氏(Roche)能否就此号令群雄？</span></a></h1></li><li><h1><a target=_blank href="http://mp.weixin.qq.com/s?__biz=MzI5NzY0NDQyNQ==&amp;mid=2248284451&amp;idx=2&amp;sn=23ffd3a5bbdabadc37aa334819ec63d1&amp;chksm=ef4741c5d830c8d3bd19964d4591f35c509f5a0d258ac6e8e7bbca377eef23f4a68ddde98410&amp;scene=21#wechat_redirect" textvalue=30亿美元合作终止，基因泰克放弃现货型TCR-T细胞疗法开发 linktype=text imgurl imgdata=null data-itemshowtype=11 tab=innerlink data-linktype=2><span>30亿美元合作终止，基因泰克放弃现货型TCR-T细胞疗法开发</span></a></h1></li><li><h1><span>其它公开资料</span></h1></li></ul><section><span></span></section><section><img data-backh=19 data-backw=578 data-imgfileid=100850999 data-ratio=0.03333333333333333 data-src="https://mmbiz.qpic.cn/mmbiz_png/Lkw2iaE07M9VdpWTCkMvY4ibwPdadaqz8TiaC6QUHo2ay416OJfe0eCs0bgZ74JoSIoCm8qJDHeicdictolYDRhandw/640?wx_fmt=other&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp" data-w=1080 src="https://mmbiz.qpic.cn/mmbiz_png/Lkw2iaE07M9VdpWTCkMvY4ibwPdadaqz8TiaC6QUHo2ay416OJfe0eCs0bgZ74JoSIoCm8qJDHeicdictolYDRhandw/640?wx_fmt=other&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp"><br></section><section><section><section><section><section powered-by=xiumi.us><p><em><em><span><em><em><em><em><span>封面图来源：Genentech<em><em><span><em><em><em><em><span></span></em></em></em></em></span></em></em></span></em></em></em></em></span></em></em></p><section data-mpa-template=t mpa-from-tpl=t><section data-mpa-template=t mpa-from-tpl=t><section mpa-from-tpl=t><section data-width=100% mpa-from-tpl=t><section mpa-from-tpl=t><section data-autoskip=1 mpa-from-tpl=t><p hm_fix=315:410 mpa-is-content=t><strong><span mpa-is-content=t>版权声明/免责声明</span></strong></p><p hm_fix=315:410 mpa-is-content=t><span mpa-is-content=t>本文为原创文章。</span></p><p hm_fix=315:410 mpa-is-content=t><span mpa-is-content=t>本文仅作信息交流之目的，不提供任何商用、医用、投资用建议。</span></p><p><span mpa-is-content=t>文中图片、视频、字体、音乐等素材或为药时代购买的授权正版作品，或来自微信公共图片库，或取自公司官网/网络，部分素材根据CC0协议使用，版权归拥有者，药时代尽力注明来源。</span></p><p><span mpa-is-content=t>如有任何问题，请与我们联系。</span></p><p><span mpa-is-content=t>衷心感谢!</span></p><p><span mpa-is-content=t>药时代官方网站:www.drugtimes.cn</span></p><p><span mpa-is-content=t>联系方式:</span></p><p><span mpa-is-content=t>电话:13651980212</span></p><p><span mpa-is-content=t>微信:27674131</span></p><p><span mpa-is-content=t>邮箱:contact@drugtimes.cn</span></p></section></section></section></section></section></section></section></section></section></section></section><section data-mpa-template=t data-from=yb-recommend-list><section data-mpa-template=t data-from=yb-recommend-list><section data-mpa-template=t data-from=yb-recommend data-recommend-article-type=normal data-recomment-template-id=1 data-recommend-article-id=2248334562_1 data-recommend-article-time=1723779762 data-recommend-article-cover="https://mmbiz.qpic.cn/sz_mmbiz_jpg/Lkw2iaE07M9VbiaUia6LAAPMmRXgFt1qdUwtwCA0yicET5YGtSyz4tMruj6bnYeiadIFqRviaGdfjMgjVib5ohwgibTqvg/0?wx_fmt=jpeg" data-recommend-article-title=最高降幅79%！美国医保最终协议价公布 data-recommend-article-content-url="https://mp.weixin.qq.com/s?__biz=MzI5NzY0NDQyNQ==&amp;mid=2248334562&amp;idx=1&amp;sn=9cccc28d2c83144496c826f73970336f&amp;chksm=ef478404d8300d121fb3f00556ea9fe544673dd3cd60d3e8c4c931551617d9cec5228b05f095#rd"><a href="https://mp.weixin.qq.com/s?__biz=MzI5NzY0NDQyNQ==&amp;mid=2248334562&amp;idx=1&amp;sn=9cccc28d2c83144496c826f73970336f&amp;chksm=ef478404d8300d121fb3f00556ea9fe544673dd3cd60d3e8c4c931551617d9cec5228b05f095&amp;scene=21#wechat_redirect" data-linktype=1><section data-recommend-type=normal data-recommend-tid=1 data-mid><section data-mid><section data-mid><span><img data-imgfileid=100851000 data-ratio=0.425531914893617 data-src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/Lkw2iaE07M9VbiaUia6LAAPMmRXgFt1qdUwtwCA0yicET5YGtSyz4tMruj6bnYeiadIFqRviaGdfjMgjVib5ohwgibTqvg/640?wx_fmt=jpeg" data-w=799 src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/Lkw2iaE07M9VbiaUia6LAAPMmRXgFt1qdUwtwCA0yicET5YGtSyz4tMruj6bnYeiadIFqRviaGdfjMgjVib5ohwgibTqvg/640?wx_fmt=jpeg"></span></section><section data-mid><p data-recommend-title=t data-mid>最高降幅79%！美国医保最终协议价公布</p></section></section></section></a></section><br><section data-mpa-template=t data-from=yb-recommend data-recommend-article-type=normal data-recomment-template-id=1 data-recommend-article-id=2248334331_1 data-recommend-article-time=1723689028 data-recommend-article-cover="https://mmbiz.qpic.cn/sz_mmbiz_jpg/Lkw2iaE07M9XmibhVOMaQo1FQsF2EkKDTlZWwZKiaEjHAmDgMRlbmHgbV7n6LY18dVlvhwbKhtU20ic4z0ln8iaQDEA/0?wx_fmt=jpeg" data-recommend-article-title=租金减免!创新基金!专业辅导!勃林格殷格翰邀您参赛 data-recommend-article-content-url="https://mp.weixin.qq.com/s?__biz=MzI5NzY0NDQyNQ==&amp;mid=2248334331&amp;idx=1&amp;sn=ae1bc2eebfa3d027fc3e06b747a66f86&amp;chksm=ef47831dd8300a0b289b56b26a42d6e8d44efe770dfc23b93836f29f6a47fb81eb31b0d7b96a#rd"><a href="https://mp.weixin.qq.com/s?__biz=MzI5NzY0NDQyNQ==&amp;mid=2248334331&amp;idx=1&amp;sn=ae1bc2eebfa3d027fc3e06b747a66f86&amp;chksm=ef47831dd8300a0b289b56b26a42d6e8d44efe770dfc23b93836f29f6a47fb81eb31b0d7b96a&amp;scene=21#wechat_redirect" data-linktype=1><section data-recommend-type=normal data-recommend-tid=1 data-mid><section data-mid><section data-mid><span><img data-imgfileid=100851001 data-ratio=0.42474916387959866 data-src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/Lkw2iaE07M9XmibhVOMaQo1FQsF2EkKDTlZWwZKiaEjHAmDgMRlbmHgbV7n6LY18dVlvhwbKhtU20ic4z0ln8iaQDEA/640?wx_fmt=jpeg" data-w=897 src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/Lkw2iaE07M9XmibhVOMaQo1FQsF2EkKDTlZWwZKiaEjHAmDgMRlbmHgbV7n6LY18dVlvhwbKhtU20ic4z0ln8iaQDEA/640?wx_fmt=jpeg"></span></section><section data-mid><p data-recommend-title=t data-mid>租金减免!创新基金!专业辅导!勃林格殷格翰邀您参赛</p></section></section></section></a></section><br><section data-mpa-template=t data-from=yb-recommend data-recommend-article-type=normal data-recomment-template-id=1 data-recommend-article-id=2248334105_1 data-recommend-article-time=1723628499 data-recommend-article-cover="https://mmbiz.qpic.cn/sz_mmbiz_jpg/Lkw2iaE07M9WcbMDwXtNibxiaYF7ew5SpDRWUCMm1GAibPauu0CgVZsfxPOEnCUjKSYjxFp3otPZQKsaUnZpZXiczUw/0?wx_fmt=jpeg" data-recommend-article-title="股价暴涨220% ！“卖不动” 的CGT再成焦点" data-recommend-article-content-url="https://mp.weixin.qq.com/s?__biz=MzI5NzY0NDQyNQ==&amp;mid=2248334105&amp;idx=1&amp;sn=cc4c2f99fbc0a51efed730c32714180e&amp;chksm=ef4783ffd8300ae93b328819cd0402e5141948b6ab4c0d31a161428f3172fd5eacfc0f7c47b6#rd"><a href="https://mp.weixin.qq.com/s?__biz=MzI5NzY0NDQyNQ==&amp;mid=2248334105&amp;idx=1&amp;sn=cc4c2f99fbc0a51efed730c32714180e&amp;chksm=ef4783ffd8300ae93b328819cd0402e5141948b6ab4c0d31a161428f3172fd5eacfc0f7c47b6&amp;scene=21#wechat_redirect" data-linktype=1><section data-recommend-type=normal data-recommend-tid=1 data-mid><section data-mid><section data-mid><span><img data-imgfileid=100851002 data-ratio=0.4269788182831661 data-src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/Lkw2iaE07M9WcbMDwXtNibxiaYF7ew5SpDRWUCMm1GAibPauu0CgVZsfxPOEnCUjKSYjxFp3otPZQKsaUnZpZXiczUw/640?wx_fmt=jpeg" data-w=897 src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/Lkw2iaE07M9WcbMDwXtNibxiaYF7ew5SpDRWUCMm1GAibPauu0CgVZsfxPOEnCUjKSYjxFp3otPZQKsaUnZpZXiczUw/640?wx_fmt=jpeg"></span></section><section data-mid><p data-recommend-title=t data-mid>股价暴涨220% ！“卖不动” 的CGT再成焦点</p></section></section></section></a></section></section><section><mp-common-videosnap data-pluginname=mpvideosnap data-url="https://findermp.video.qq.com/251/20304/stodownload?encfilekey=rjD5jyTuFrIpZ2ibE8T7YmwgiahniaXswqzddqCiaayRal5Tn6nYaQp9UicicJ9RTOyXRvJ62VOWEfEHbHSzUhuIUxqFKchjjCFxI2iaoAuwctYy68mbZicqOENChg&amp;token=cztXnd9GyrHvLBxibgTic0jTW7fjHU93DkTsicPltzBgdPnac41icbW6OZ0PGByHU66Y4u8LZ2ZODultw4O02gK6BYibVQFgMYCMaOh01QXuGNiauTP67CJ7CKSvW4hMU4aC6e&amp;idx=1&amp;dotrans=0&amp;hy=SH&amp;m=&amp;scene=2&amp;uzid=2" data-headimgurl=http://wx.qlogo.cn/finderhead/Q3auHgzwzM4njP4xWmU6ia9smibzXzLWAg6rrbEuZuiaQlgrM8dYRicffA/0 data-username=v2_060000231003b20faec8c7e38d1ac2d6c903ed35b0779629073dbff92eb25305ea1c0e2b627a@finder data-nickname=药时代 data-desc="2024年8月2日，Adaptimmune宣布其TCR-T细胞疗法Afami-cel已经获得美国FDA批准上市，用于治疗晚期滑膜肉瘤。值得一提的是，这是全球首款获批上市的TCR-T细胞疗法，具有重大里程碑意义，给晚期滑膜肉瘤患者带来“变革性”治疗手段的同时，也填补了TCR-T赛道的空白，提振了行业信心。Afami-cel申报BLA并获批上市是基于关键试验SPEARHEAD-1的临床数据：转移性或不可切除滑膜肉瘤患者的总体缓解率（ORR）为39%，中位缓解持续时间约为12个月。以往接受过两种或两种以上疗法的滑膜肉瘤患者的中位总生存期（OS）小于12个月，而接受Afami-cel治疗患者的中位总生存期约为17个月，优于历史对照数据。在接受Afami-cel治疗两年后，70%的反应者仍然存活。全球首款TCR-T细胞疗法获批上市令行业振奋，而国内也在加速推进TCR-T细胞疗法的研发。据不完全统计，国内布局TCR-T细胞疗法的企业有17家，其中大部分都已经进入临床研究阶段。#TCR-T #滑膜肉瘤 #细胞疗法 #CGT #全球首款 #新药研发 #创新药 @药时代 @创新药时代 （药时代原创作品，上传于2024年8月2日。版权归拥有者所有，仅供感兴趣的个人谨慎参考。非商用，非医用，非投资用。任何问题，请联系我们。电话：13651980212。微信：27674131。邮箱：contact@drugtimes.cn。衷心感谢！）" data-nonceid=6318971645994625605 data-type=video data-mediatype=undefined data-authiconurl=https://dldir1v6.qq.com/weixin/checkresupdate/icons_filled_channels_authentication_enterprise_a2658032368245639e666fb11533a600.png data-from=new data-width=1080 data-height=1920 data-id=export/UzFfAgtgekIEAQAAAAAA5Tc33tCtxQAAAAstQy6ubaLX4KHWvLEZgBPEladwR2JwH6GLzNPgMIsdpg7rKKO1biSLKbPcZFcM data-isdisabled=0 data-errortips></mp-common-videosnap></section><section><mp-common-videosnap data-pluginname=mpvideosnap data-url="https://findermp.video.qq.com/251/20304/stodownload?encfilekey=rjD5jyTuFrIpZ2ibE8T7YmwgiahniaXswqzjH3JWqjdjKLcibwZqicU6BgkbZAIcA3Fyq7v4UQLkqC7IC3FKTtqdXkEEaJUI3uxWKCtJ4EAnSUFyVG9QFIuP34A&amp;token=cztXnd9GyrHvLBxibgTic0jTW7fjHU93DkxAYWPKZKRiaNLJ5YwtLIibAZSb7rgR3Oywic1UWfSL3IC7GcYDwfx5RM80QYb71tXXEExCyzOvoDKBWibTOXtDuCzBEBh2ayibfSD&amp;idx=1&amp;dotrans=0&amp;hy=SH&amp;m=&amp;scene=2&amp;uzid=2" data-headimgurl=http://wx.qlogo.cn/finderhead/Q3auHgzwzM4njP4xWmU6ia9smibzXzLWAg6rrbEuZuiaQlgrM8dYRicffA/0 data-username=v2_060000231003b20faec8c7e38d1ac2d6c903ed35b0779629073dbff92eb25305ea1c0e2b627a@finder data-nickname=药时代 data-desc="2024年7月31日，国家药监局发布《优化创新药临床试验审评审批试点工作方案》，针对创新药临床试验限速的关键环节，提出拟“探索建立全面提升药物临床试验质量和效率的工作制度和机制，实现30个工作日内完成创新药临床试验申请审评审批，缩短药物临床试验启动用时”的工作目标。据悉，此次试点工作为期1年。试点期间，试点区域内至少完成10个品种的临床试验申请审评审批并启动临床试验。据规划，2024年8月底前完成试点区域、试点机构确认，并启动试点项目申请；2025年1月开展中期评估；2025年7月总结试点工作经验。《试点方案》明确，申请人不受区域限制，但需在境内外至少获批过3个创新药临床试验申请，有丰富的临床试验实施及药物警戒管理经验，能够在临床试验申请提交前对临床试验项目进行全面的风险评估并制定有效的风险管理计划。#临床试验 #国家药监局 #创新药 #审评审批 #试点方案 #新药研发 #全链条创新支持 @药时代 @创新药时代 （药时代原创作品，上传于2024年8月1日。版权归拥有者所有，仅供感兴趣的个人谨慎参考。非商用，非医用，非投资用。任何问题，请联系我们。电话：13651980212。微信：27674131。邮箱：contact@drugtimes.cn。衷心感谢！）" data-nonceid=9939099161464595255 data-type=video data-mediatype=undefined data-authiconurl=https://dldir1v6.qq.com/weixin/checkresupdate/icons_filled_channels_authentication_enterprise_a2658032368245639e666fb11533a600.png data-from=new data-width=1080 data-height=1920 data-id=export/UzFfAgtgekIEAQAAAAAAfY0Y4GysLAAAAAstQy6ubaLX4KHWvLEZgBPEnKcYPjIid6aLzNPgMIsZNy8jFTFVv0lhueVtIddR data-isdisabled=0 data-errortips></mp-common-videosnap></section><p><strong msttexthash=746473 msthash=6101><img data-backh=321 data-backw=578 data-imgfileid=100851003 data-ratio=0.5555555555555556 data-src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/Lkw2iaE07M9Wygte8vbem4q1cPZBciaTIQ9nSUQhjNkGKmycYaxGeW4TUwxPibkUwCtuyCMYKTGkn6LK1kw0ibH9Lw/640?wx_fmt=other&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp" data-w=1080 src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/Lkw2iaE07M9Wygte8vbem4q1cPZBciaTIQ9nSUQhjNkGKmycYaxGeW4TUwxPibkUwCtuyCMYKTGkn6LK1kw0ibH9Lw/640?wx_fmt=other&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp"></strong></p></section><section powered-by=xiumi.us><section><section><strong><img data-imgfileid=100851004 data-ratio=1.2105263157894737 data-src="https://mmbiz.qpic.cn/mmbiz_gif/US10Gcd0tQH9Pa6nvdh6CaICF2az6V5pybfOejYGmQAonWMsSLUJGhoyZcv02NIVLMSxvoUf3e6PVsSvibnruxg/640?wx_fmt=gif&amp;wxfrom=5&amp;wx_lazy=1&amp;tp=webp" data-type=gif data-w=38 src="https://mmbiz.qpic.cn/mmbiz_gif/US10Gcd0tQH9Pa6nvdh6CaICF2az6V5pybfOejYGmQAonWMsSLUJGhoyZcv02NIVLMSxvoUf3e6PVsSvibnruxg/640?wx_fmt=gif&amp;wxfrom=5&amp;wx_lazy=1&amp;tp=webp"></strong><span><strong><span><strong><strong><span>每天有几千位朋友们在这里相聚！</span></strong></strong></span></strong></span></section></section></section><p><mp-style-type data-value=3></mp-style-type></p></div><hr><a href=https://mp.weixin.qq.com/s/TwMxcAG6r7jnwiUPzVnO7g ,target=_blank rel="noopener noreferrer">原文链接</a></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/fetched/ rel=tag>fetched</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/%E8%8D%AF%E6%97%B6%E4%BB%A3/ rel=tag>药时代</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/2024-09/%E9%83%91%E5%B7%9E%E6%9C%80%E9%9A%BE%E7%9A%84%E6%90%AC%E8%BF%81_%E5%8F%88%E6%B3%A1%E6%B1%A4_/ rel=prev><span class=pager__subtitle>«&#8201;Previous</span><p class=pager__title>郑州最难的搬迁，又泡汤！</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/2024-09/adobe%E6%96%B0%E5%87%BAfirefly%E8%A7%86%E9%A2%91%E6%A8%A1%E5%9E%8B_2%E5%88%86%E9%92%9F%E9%80%9F%E6%88%90%E9%AB%98%E6%B8%85%E5%A4%A7%E7%89%87/ rel=next><span class=pager__subtitle>Next&#8201;»</span><p class=pager__title>Adobe新出Firefly视频模型 2分钟速成高清大片</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Search… name=q aria-label=Search…>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/2025-09/%E9%97%B2%E9%B1%BC%E4%B8%8A%E9%82%A3%E4%BA%9B%E9%80%86%E5%A4%A9%E7%9A%84%E6%B5%8B%E5%BA%8F%E4%BB%AA/>闲鱼上那些逆天的测序仪</a></li><li class=widget__item><a class=widget__link href=../../../posts/2025-09/%E8%AF%B4%E8%B5%B7%E8%BE%9B%E8%8A%B7%E8%95%BE_%E6%88%91%E6%83%B3%E8%B5%B7%E6%97%A9%E5%B9%B4%E4%B8%80%E4%BA%9B%E5%93%81%E5%91%B3_%E7%8B%AC%E7%89%B9_%E7%9A%84%E6%81%90%E6%80%96%E7%89%87/>说起辛芷蕾，我想起早年一些品味“独特”的恐怖片</a></li><li class=widget__item><a class=widget__link href=../../../posts/2025-09/%E5%A4%9A%E6%AC%A1%E7%94%9F%E5%AD%90%E5%90%8E_28%E5%B2%81%E5%86%9C%E6%9D%91%E6%99%BA%E9%9A%9C%E5%A5%B3%E5%AD%A9%E6%82%84%E7%84%B6%E7%A6%BB%E4%B8%96/>多次生子后，28岁农村智障女孩悄然离世</a></li><li class=widget__item><a class=widget__link href=../../../posts/2025-09/openai%E7%BD%95%E8%A7%81%E5%8F%91%E8%AE%BA%E6%96%87_%E6%88%91%E4%BB%AC%E6%89%BE%E5%88%B0%E4%BA%86ai%E5%B9%BB%E8%A7%89%E7%9A%84%E7%BD%AA%E9%AD%81%E7%A5%B8%E9%A6%96/>OpenAI罕见发论文：我们找到了AI幻觉的罪魁祸首</a></li><li class=widget__item><a class=widget__link href=../../../posts/2025-09/%E5%8D%97%E4%BA%AC%E5%8D%96%E6%B7%AB%E5%A4%B4%E7%9B%AE1_34%E4%BA%BF%E6%B8%AF%E5%85%83%E8%A2%AB%E7%91%9E%E9%93%B6%E5%8E%9F%E5%89%AF%E6%80%BB%E7%9B%91%E7%A7%81%E5%90%9E/>南京卖淫头目1.34亿港元被瑞银原副总监私吞</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/duty/>Duty</a></li><li class=widget__item><a class=widget__link href=../../../categories/duty2/>Duty2</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/cnbeta/ title=Cnbeta>Cnbeta (148)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/datawhale/ title=Datawhale>Datawhale (9)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/drpei/ title=Drpei>Drpei (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/fetched/ title=Fetched>Fetched (755)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/githubdaily/ title=GitHubDaily>GitHubDaily (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E4%B8%81%E9%A6%99%E5%9B%AD/ title=丁香园>丁香园 (30)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E4%BA%BA%E7%89%A9/ title=人物>人物 (15)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E5%8D%97%E6%96%B9%E5%91%A8%E6%9C%AB/ title=南方周末>南方周末 (11)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E5%B0%8F%E4%BC%97%E8%BD%AF%E4%BB%B6/ title=小众软件>小众软件 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E5%B0%8F%E5%A4%A7%E5%A4%AB%E6%BC%AB%E7%94%BB/ title=小大夫漫画>小大夫漫画 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E5%B0%91%E6%95%B0%E6%B4%BE/ title=少数派>少数派 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E5%BE%AA%E5%9B%A0%E7%BC%89%E8%8D%AF/ title=循因缉药>循因缉药 (9)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%96%B0%E4%B9%A1%E5%9C%9F/ title=新乡土>新乡土 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%98%9F%E7%90%83%E5%95%86%E4%B8%9A%E8%AF%84%E8%AE%BA/ title=星球商业评论>星球商业评论 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%9C%88%E5%85%89%E5%8D%9A%E5%AE%A2/ title=月光博客>月光博客 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%9C%AA%E9%97%BBcode/ title=未闻Code>未闻Code (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%A7%BD%E8%BE%B9%E5%BE%80%E4%BA%8B/ title=槽边往事>槽边往事 (9)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%AF%8F%E6%97%A5%E4%BA%BA%E7%89%A9/ title=每日人物>每日人物 (10)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%B5%AA%E6%BD%AE%E5%B7%A5%E4%BD%9C%E5%AE%A4/ title=浪潮工作室>浪潮工作室 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%B5%AE%E4%B9%8B%E9%9D%99/ title=浮之静>浮之静 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E7%81%BC%E8%A7%81/ title=灼见>灼见 (8)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E7%86%8A%E8%A8%80%E7%86%8A%E8%AF%AD/ title=熊言熊语>熊言熊语 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E7%94%9F%E4%BF%A1%E6%8A%80%E8%83%BD%E6%A0%91/ title=生信技能树>生信技能树 (10)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E7%94%9F%E4%BF%A1%E8%8F%9C%E9%B8%9F%E5%9B%A2/ title=生信菜鸟团>生信菜鸟团 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E7%9F%A5%E8%AF%86%E5%88%86%E5%AD%90/ title=知识分子>知识分子 (14)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E7%BD%91%E6%98%93%E6%95%B0%E8%AF%BB/ title=网易数读>网易数读 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E8%B4%A2%E6%96%B0/ title=财新>财新 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E8%B4%A2%E7%BB%8F%E4%B8%89%E5%88%86%E9%92%9F/ title=财经三分钟>财经三分钟 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E8%B5%9B%E5%85%88%E7%94%9F/ title=赛先生>赛先生 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E9%83%91%E5%B7%9E%E6%A5%BC%E5%B8%82/ title=郑州楼市>郑州楼市 (32)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2025 文字轨迹.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>